Experience

Institut de la Vision

• France
• Research Services
• 100 - 200 Employee

• Research Associate

  • 2018 - Present

  Ville de Paris, Île-de-France, France Evaluation of RdCVF active peptide’s effect on retinitis pigmentosa. Under the direction of Thierry Léveillard. Département of Genetics: Institut de la Vision Paris. UMR S -968. Paris. France. Molecular mechanisms of NXNL1 gene’s alternative splicing. Under the direction of Thierry Léveillard. Département of Genetics: Institut de la Vision Paris. UMR S -968. Paris. France. Identification of genes splicing altered after NCL overexpression in retinoblastoma: in collaboration with David… Show more Evaluation of RdCVF active peptide’s effect on retinitis pigmentosa. Under the direction of Thierry Léveillard. Département of Genetics: Institut de la Vision Paris. UMR S -968. Paris. France. Molecular mechanisms of NXNL1 gene’s alternative splicing. Under the direction of Thierry Léveillard. Département of Genetics: Institut de la Vision Paris. UMR S -968. Paris. France. Identification of genes splicing altered after NCL overexpression in retinoblastoma: in collaboration with David Cobrinick, Vision Center Children's Hospital University Southern California (USC). Los Angeles. USA. Single-Cell RNA-Seq Reveals Transcriptional Heterogeneity between lamprey rod and cone: in collaboration with Alapakkam Sampath, Jules Stein Eye Institute, Department of Ophthalmology, University California Los Angeles (UCLA). Los Angeles. USA. Show less



University of Southern California

• United States
• Higher Education
• 700 & Above Employee

• Visiting Postdoc

  • Sep 2019 - Sep 2019

  Los Angeles, Californie, États-Unis The origin of the RdCVF metabolic signaling: in collaboration with Alain Van Dorsselaer, Laboratoire Spectrométrie de Masse BioOrganique (LSMBO). Strasbourg. France and Gordon Fain, Department of Integrative Biology and Physiology (UCLA). Los Angeles. USA. Nucleolin interacts with NRE (NXNL1 Redefinition Element): in collaboration with Alain Lescure, Department of molecular and cellular biology. Institute of RNA architecture and reactivity. Strasbourg. France. NXNL1 does not encode for a… Show more The origin of the RdCVF metabolic signaling: in collaboration with Alain Van Dorsselaer, Laboratoire Spectrométrie de Masse BioOrganique (LSMBO). Strasbourg. France and Gordon Fain, Department of Integrative Biology and Physiology (UCLA). Los Angeles. USA. Nucleolin interacts with NRE (NXNL1 Redefinition Element): in collaboration with Alain Lescure, Department of molecular and cellular biology. Institute of RNA architecture and reactivity. Strasbourg. France. NXNL1 does not encode for a selenoprotein: in collaboration with Elias Arnér and Arne Holmgren, Department of Medical Biochemistry and Biophysics. Karolinska Institute. Stockholm. Sweden. Show less



UCLA

• United States
• Higher Education
• 700 & Above Employee

• Visiting Student

  • Dec 2016 - Jul 2018

  Los Angeles, Californie, États-Unis



Institut de la Vision

• France
• Research Services
• 100 - 200 Employee

• Engineer

  • 2006 - 2014

  Under the direction of Thierry Léveillard. Identification of RdCVF’s receptor. Mode of action of RdCVF and it’s signalization. Identification of RdCVF agonist: in collaboration with Sanofi.

• Research Assistant

  • 2004 - 2006

  Ville de Paris, Île-de-France, France Cellular and molecular physiopathology of the retina: INSERM group. U592.Paris. France. RNAi training in the laboratory of Prof. Peter Humphries in Smurfit Institute of Genetics, Trinity College. Dublin. Ireland. Replication and reformatting of a mouse neuronal retina library in the laboratory of Didier BUSSO Institut de Génétique et de Biologie Moléculaire et Cellulaire. Strasbourg. France.



Hopital de St Cloud

• Secrétaire médicale

  • Dec 2002 - May 2003

  Saint Cloud